Benzo[c][1,2,5]oxadiazole-based nitrogen-containing heterocycles: COX inhibition, in vivo gastroprotective activity, and computational insights
Authors: Hussein, Modather F; El-Hema, Hagar S; Salama, Abeer; Manni, Emad; Bakhaat, Gamal Abdelrahman; S El-Nasser, Karam; Osman, Amany M A
Source journal: Bioorganic chemistry (2026-11-14)
DOI: 10.1016/j.bioorg.2026.110766
Abstract
Cancer remains a major therapeutic challenge, motivating the development of multifunctional compounds with anticancer and gastroprotective potential. Herein, nitrogen-containing heterocyclic derivatives (1-6) were synthesized, characterized, and evaluated against HCT-116 and MCF-7 cancer cells and normal WI-38 fibroblasts. Compound 2c exhibited the strongest antiproliferative activity against HCT-116 (IC(50) = 20.01 muM; apparent SI = 31.99) and MCF-7 (IC(50) = 11.21 muM; apparent SI = 57.13). Compound 6 showed corresponding IC(50) values of 24.82 and 13.27 muM and apparent SI values of 16.90 and 31.60. In preliminary fluorometric assays, 2c and 6 exhibited apparent COX-2 inhibition (IC(50) = 0.092 and 0.203 muM, respectively) and COX-1 inhibition (IC(50) = 17.71 and 11.75 muM, respectively), based on four-parameter logistic (4PL) analysis at 50% absolute inhibition. In an ethanol-induced gastric ulcer model, 2c and 6 reduced the ulcer index to 1.40 +/- 1.67 and 4.40 +/- 1.67, corresponding to 97.99% and 93.67% protection, respectively. Gastroprotection was accompanied by changes in gastric GSH, MDA, NF-kappaB, PGE(2), and VEGF, alongside histopathological improvement and histological scoring. These in vivo observations provide complementary evidence of gastroprotective activity but do not establish COX inhibition as its underlying mechanism. Docking scores for 2c/6 were - 7.49/-6.66 kcal/mol against ovine COX-1 (1EQG) and - 5.55/-4.64 kcal/mol against murine COX-2 (3LN1). Molecular dynamics simulations (100 ns) suggested relatively stable COX-2 complexes, particularly for 6, whereas its COX-1 complex showed greater instability. MM/PBSA estimates were - 15.77/-13.67 and - 11.24/-21.60 kcal/mol for COX-1 and COX-2, respectively. DFT energy gaps were 1.967 and 2.018 eV, while ADMET predicted low gastrointestinal absorption. Because the experimental COX isoforms originated from different species and fluorescence interference was not excluded, the enzyme results remain preliminary. Overall, 2c and 6 warrant further investigation as multifunctional anticancer and gastroprotective candidates.
Related topics
Related open access articles
- Development and Validation Molecular Docking Analysis of Human serum albumin (HSA)
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- Curcumin and pipernonaline to curb diabetes the natural way: A molecular modeling, docking and dynamics simulation study
- DENSITY FUNCTIONAL THEORY ANALYSIS AND MOLECULAR DOCKING EVALUATION OF 8-CHLOROQUINOLINE 2-CARBALDEHYDE
- Thermochemical, DFT, Molecular Docking and Pharmacokinetic Studies of Methyl β-D-galactopyranoside Esters
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.